B.-Y. Li et al. / Carbohydrate Research 345 (2010) 1708–1712
1711
1H, indole), 7.15 (s, 1H, indole), 7.05 (t, J 7.6 Hz, 1H, indole), 6.91 (t, J
7.6 Hz, 1H, indole), 5.68 (s, 1H, CH), 5.26–5.23 (m, 2H, 3-H,4-H),
5.10 (t, J2,3 9.6 Hz, J1,2 8.8 Hz, 1H, 2-H), 4.16–4.06 (m, 3H, 1-H, 5-
H, 6a-H), 3.92 (dd, J6a,6b 9.2 Hz, J6b,5 4.8 Hz, 1H, 6b-H), 1.21 (s, 9H,
C(CH3)3), 1.19 (s, 9H, C(CH3)3), 1.16 (s, 9H, C(CH3)3), 1.03 (s, 9H,
C(CH3)3). 13C NMR: d176.83, 176.30, 176.18, 176.11, 151.42,
146.34, 136.33, 128.65, 124.98, 123.26, 122.41, 121.30, 118.61,
118.50, 116.78, 111.61, 85.31, 71.20, 70.35, 68.92, 67.40, 61.15,
53.47, 26.95, 26.72, 26.68, 26.65, 26.60. HR-ESI-MS: Calcd for
(d, J1,2 8.8 Hz, 1H, 1-H), 4.13 (t, J5,6a 6.4 Hz, J5,6b 6.8 Hz, 1H, 5-H),
4.06 (dd, J6a,6b 10.4 Hz, J5,6b 6.8 Hz, 1H, 6b-H), 3.92 (dd, J6a,6b
10.4 Hz, J5,6a 6.4 Hz, 1H, 6a-H), 2.40 (s, 3H, CH3), 1.26 (s, 9H,
C(CH3)3), 1.17 (s, 9H, C(CH3)3), 1.16 (s, 9H, C(CH3)3), 1.04 (s, 9H,
C(CH3)3). 13C NMR: d 176.86, 176.26, 176.23, 176.17, 151.94,
146.06, 134.91, 131.94, 127.93, 126.08, 123.29, 120.19, 118.57,
118.26, 111.55, 110.52, 85.54, 71.36, 70.49, 69.02, 67.49, 61.37,
52.90, 27.04, 26.74, 26.70, 26.64, 11.96. HR-ESI-MS: Calcd for
C
42H57N3O11 [M+Na]+: 802.3885, found: 802.3867.
C
41H55N3O11 [M+Na]+: 788.3729, found: 788.3713.
3.2.6. N-[5-Methoxy-Indol-3-yl-(4-nitrophenyl)methyl]-(2,3,4,6-
tetra-O-pivaloyl-b- -galactosyl)amine (3j)
3.2.2. N-[Indol-3-yl-(2-nitrophenyl)methyl]-(2,3,4,6-tetra-O-
pivaloyl-b- -galactosyl)amine (3b)
D
lH NMR: d 10.86 (s, 1H, indole NH), 8.18 (d, J 8.4 Hz, 2H, ph), 7.74
(d, J 8.4 Hz, 2H, ph), 7.24 (d, J 8.8 Hz, 1H, indole), 7.04 (d, J 2.0 Hz,
1H, indole), 6.96 (s, 1H, indole), 6.72 (dd, J1 2.0 Hz, J2 8.8 Hz, 1H, in-
dole), 5.64 (s, 1H, CH), 5.25–5.23 (m, 2H, 3-H,4-H), 5.09 (t, J2,3
10.0 Hz, J1,2 9.6 Hz, 1H, 2-H), 4.16–4.08 (m, 3H, 1-H, 5-H, 6a-H),
3.94 (dd, J6a,6b 10.0 Hz, J6b,5 6.0 Hz, 1H, 6b-H), 3.72 (s, 3H, OCH3),
1.19–1.16 (m, 27H, three C(CH3)3), 1.03 (s, 9H, C(CH3)3). 13C
NMR: d 176.86, 176.32, 176.22, 176.13, 153.08, 151.91, 151.40,
146.40, 131.27, 128.70, 125.36, 123.26, 116.45, 112.29, 111.46,
100.31, 99.50, 85.55, 71.24, 70.37, 68.89, 67.41, 61.22, 55.20,
53.30, 26.96, 26.75, 26.68, 26.62. HR-ESI-MS: Calcd for
D
lH NMR: d 11.01 (s, 1H, indole NH), 8.18 (d, J 8.0 Hz, 1H, ph), 7.84
(d, J 8.0 Hz, 1H, ph), 7.65 (t, J 8.0, 7.2 Hz, 1H, ph), 7.60 (d, J 8.0 Hz,
1H, indole), 7.49 (t, J 7.6 Hz, 1H, ph), 7.34 (d, J 8.0 Hz, 1H, indole),
7.06 (t, J 7.6 Hz, 1H, indole), 6.93–6.89 (m, 2H, indole), 6.10 (s, 1H,
CH), 5.26–5.24 (m, 2H, 3-H, 4-H), 5.06 (t, J2,3 9.6 Hz, J1,2 9.6 Hz,
1H, 2-H), 4.22–4.18 (m, 2H, 1-H, 5-H), 4.04 (dd, J6a,6b 10.8 Hz, J6a,5
7.6 Hz, 1H, 6a-H), 3.92 (dd, J6a,6b 10.8 Hz, J6b,5 7.2 Hz, 1H, 6b-H),
1.18 (s, 9H, C(CH3)3), 1.17 (s, 9H, C(CH3)3), 1.13 (s, 9H, C(CH3)3),
1.03 (s, 9H, C(CH3)3). 13C NMR: d 177.00, 176.25, 176.19, 176.10,
149.61, 146.34, 137.14, 136.26, 132.30, 129.70, 128.08, 125.19,
123.68, 122.97, 121.33, 118.67, 118.53, 116.22, 111.58, 85.81,
71.24, 70.40, 68.87, 67.42, 61.20, 54.82, 26.93, 26.70, 26.68,
26.61. HR-ESI-MS: Calcd for C41H55N3O11 [M+Na]+: 788.3729,
found: 788.3723.
C
42H58N3O12 [M+Na]+: 818.3834, found: 818.3822.
3.2.7. N-[6-Chloro-Indol-3-yl-(4-nitrophenyl)methyl]-(2,3,4,6-
tetra-O-pivaloyl-b- -galactosyl)amine (3k)
D
lH NMR: d 11.15 (s, 1H, indole NH), 8.16 (d, J 8.8 Hz, 2H, ph), 7.71
(d, J 8.8 Hz, 2H, ph), 7.54 (d, J 8.4 Hz, 1H, indole), 7.38 (d, J 1.6 Hz,
1H, indole), 7.22 (s, 1H, indole), 6.91 (dd, J1 8.4 Hz, J2 1.6 Hz, 1H, in-
dole), 5.64 (s, 1H, CH), 5.24–5.21 (m, 2H, 3-H,4-H), 5.10 (t, J2,3
9.6 Hz, J1,2 9.2 Hz, 1H, 2-H), 4.14–4.06 (m, 3H, 1-H, 5-H, 6a-H),
3.90 (dd, J6a,6b 9.6 Hz, J6b,5 6.4 Hz, 1H, 6b-H), 1.20 (s, 9H, C(CH3)3),
1.19 (s, 9H, C(CH3)3), 1.14 (s, 9H, C(CH3)3), 1.03 (s, 9H, C(CH3)3).
3.2.3. N-[Indol-3-yl-(4-cyanophenyl)methyl]-(2,3,4,6-tetra-O-
pivaloyl-b-D-galactosyl)amine (3c)
lH NMR: d 10.99 (s, 1H, indole NH), 7.77 (d, J 8.0 Hz, 2H, ph), 7.66
(d, J 8.0 Hz, 2H, ph), 7.55 (d, J 8.0 Hz, 1H, indole), 7.33 (d, J 8.0 Hz,
1H, indole), 7.12 (s, 1H, indole), 7.05 (t, J 8.0 Hz, 1H, indole), 6.90
(t, J 7.6 Hz, 1H, indole), 5.61 (s, 1H, CH), 5.26–5.23 (m, 2H, 3-H,4-
H), 5.09 (t, J2,3 9.2 Hz, J1,2 9.2 Hz, 1H, 2-H), 4.13–4.06 (m, 3H, 1-H,
5-H, 6a-H), 3.92 (dd, J6a,6b 9.6 Hz, J6b,5 6.0 Hz, 1H, 6b-H), 1.20 (s,
9H, C(CH3)3), 1.19 (s, 9H, C(CH3)3), 1.16 (s, 9H, C(CH3)3), 1.03 (s,
9H, C(CH3)3). 13C NMR: d 176.83, 176.30, 176.18, 176.09, 149.24,
136.30, 132.04, 128.49, 124.98, 122.28, 121.26, 118.76, 118.45,
116.98, 111.60, 109.49, 85.28, 71.17, 70.31, 68.94, 67.41, 61.17,
53.69, 26.95, 26.72, 26.68, 26.60. HR ESI MS: Calcd for
13C NMR:
d 176.84, 176.26, 176.20, 176.12, 151.20, 146.39,
136.52, 128.65, 128.03, 123.79, 123.32, 120.01, 118.78, 117.08,
111.18, 99.49, 85.34, 71.24, 70.29, 68.86, 67.34, 61.07, 54.82,
53.41, 26.96, 26.90, 26.72, 26.69. HR-ESI-MS: Calcd for
C
41H54ClN3O11 [M+Na]+: 822.3339, found: 822.3320.
C
42H55N3O9 [M+Na]+: 768.3830, found: 768.3813.
3.3. General procedure for the removal of the auxiliary to form
compounds 4g and 4k
3.2.4. N-[Indol-3-yl-(pyridine-3-yl)methyl]-(2,3,4,6-tetra-O-
pivaloyl-b- -galactosyl)amine (3f)
A solution of compound 3g or 3k (0.4 mmol) in dry methanol
(2 mL) was treated with a freshly prepared (0.5 M) solution of so-
dium methoxide (2 mL), which was prepared from sodium and dry
methanol. The solution was stirred until the reactant was con-
sumed (TLC control). To the mixture were added a few drops of
water, and the mixture was neutralized with acetic acid, after
which the mixture was stirred for another 4 h. Then the mixture
was extracted with EtOAc, washed with saturated aqueous NaH-
CO3, dried over MgSO4, and filtered, and the volatiles were re-
moved under vacuum. The residue was purified by column
chromatography on silica gel (CH2Cl2/MeOH = 30/1, with 0.1%
Et3N), yielding the corresponding compounds 4g or 4k.
D
lH NMR: d 10.98 (s, 1H, indole NH), 8.68 (s, 1H, py), 8.42 (br,
1H, py), 7.79 (d, J 8.0 Hz, 1H, indole), 7.55 (d, J 8.0 Hz, 1H, indole),
7.35–7.31 (m, 2H, py), 7.13 (s, 1H, indole), 7.05 (t, J 7.6 Hz, 1H, in-
dole), 6.91 (t, J 7.6 Hz, 1H, indole), 5.58 (s, 1H, CH), 5.27–5.24 (m,
2H, 3-H, 4-H), 5.09 (t, J2,3 9.6 Hz, J1,2 9.2 Hz, 1H, 2-H), 4.16–4.07
(m, 3H, 1-H, 5-H, 6a-H), 3.94 (dd, J6a,6b 10.4 Hz, J6b,5 6.0 Hz, 1H,
6b-H), 1.19 (s, 9H, C(CH3)3), 1.19 (s, 9H, C(CH3)3), 1.17 (s, 9H,
C(CH3)3), 1.03 (s, 9H, C(CH3)3). 13C NMR:
d 176.87, 176.31,
176.21, 176.07, 149.10, 148.07, 138.49, 136.20, 135.15, 134.42,
124.98, 123.28, 121.95, 121.28, 118.44, 117.30, 111.55, 85.17,
71.14, 70.39, 68.96, 67.50, 61.33, 51.71, 26.91, 26.74, 26.69,
26.64, 26.61. HR-ESI-MS: Calcd for
744.3830, found: 744.3819.
C
40H55N3O9 [M+Na]+:
3.3.1. N-[2-Metyl-Indol-3-yl-(4-nitrophenyl)methyl]amine (4g)
98:2 er, tmajor = 16.39 min and tminor = 19.74 min. lH NMR: d
10.84 (s, 1H, indole NH), 8.14 (d, J 8.8 Hz, 2H, ph), 7.74 (d, J
8.8 Hz, 2H, ph), 7.42 (d, J 8.0 Hz, 1H, indole), 7.21 (d, J 8.0 Hz, 1H,
indole), 6.93 (t, J 7.2 Hz, 1H, indole), 6.81 (t, J 7.2 Hz, 1H, indole),
5.52 (s, 1H, CH), 2.43 (s, 3H, CH3). 13C NMR: d 154.92, 145.62,
135.04, 131.73, 127.54, 126.22, 123.00, 119.96, 118.66, 118.16,
113.81, 110.36, 50.75, 11.75. HR-ESI-MS: Calcd for C16H15N3O2
[MꢀH]+: 280.1080, found: 280.1078.
3.2.5. N-[2-Metyl-Indol-3-yl-(4-nitrophenyl)methyl]-(2,3,4,6-
tetra-O-pivaloyl-b- -galactosyl)amine (3g)
D
lH NMR: d 10.92 (s, 1H, indole NH), 8.14 (d, J 8.8 Hz, 2H, ph), 7.74
(d, J 8.8 Hz, 2H, ph), 7.54 (d, J 8.0 Hz, 1H, indole), 7.21 (d, J 8.0 Hz,
1H, indole), 6.95 (t, J 7.6 Hz, 1H, indole), 6.84 (t, J 7.6 Hz, 1H, indole),
5.69 (s, 1H, CH), 5.27 (dd, J3,4 3.2 Hz, J2,3 10.0 Hz, 1H, 3-H), 5.23 (d,
J3,4 3.2 Hz, 1H, 4-H), 5.12 (t, J2,3 10.0 Hz, J1,2 8.8 Hz, 1H, 2-H), 4.24